-
1
-
-
77952311188
-
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
-
Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease Biochem. Biophys. Res. Commun. 2010, 396, 120-124
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.396
, pp. 120-124
-
-
Holmgren, A.1
Lu, J.2
-
2
-
-
0242277285
-
The thioredoxin system-From science to clinic
-
Gromer, S.; Urig, S.; Becker, K. The thioredoxin system-From science to clinic Med. Res. Rev. 2004, 24, 40-89
-
(2004)
Med. Res. Rev.
, vol.24
, pp. 40-89
-
-
Gromer, S.1
Urig, S.2
Becker, K.3
-
3
-
-
33845428642
-
Thioredoxin and related molecules-From biology to health and disease
-
Lillig, C. H.; Holmgren, A. Thioredoxin and related molecules-From biology to health and disease Antioxid. Redox Signal. 2007, 9, 25-47
-
(2007)
Antioxid. Redox Signal.
, vol.9
, pp. 25-47
-
-
Lillig, C.H.1
Holmgren, A.2
-
4
-
-
0026443077
-
Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway
-
Rubartelli, A.; Bajetto, A.; Allavena, G.; Wollman, E.; Sitia, R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway J. Biol. Chem. 1992, 267, 24161-24164
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 24161-24164
-
-
Rubartelli, A.1
Bajetto, A.2
Allavena, G.3
Wollman, E.4
Sitia, R.5
-
5
-
-
0346690291
-
Thioredoxin as a key molecule in redox signaling
-
Nakamura, H. Thioredoxin as a key molecule in redox signaling Antioxid. Redox Signal. 2004, 6, 15-17
-
(2004)
Antioxid. Redox Signal.
, vol.6
, pp. 15-17
-
-
Nakamura, H.1
-
6
-
-
38049035093
-
TRPC channel activation by extracellular thioredoxin
-
Xu, S.-Z.; Sukumar, P.; Zeng, F.; Li, J.; Jairaman, A.; English, A.; Naylor, J.; Ciurtin, C.; Majeed, Y.; Milligan, C. J.; Bahnasi, Y. M.; Al-Shawaf, E.; Porter, K. E.; Jiang, L.-H.; Emery, P.; Sivaprasadarao, A.; Beech, D. J. TRPC channel activation by extracellular thioredoxin Nature 2008, 451, 69-72
-
(2008)
Nature
, vol.451
, pp. 69-72
-
-
Xu, S.-Z.1
Sukumar, P.2
Zeng, F.3
Li, J.4
Jairaman, A.5
English, A.6
Naylor, J.7
Ciurtin, C.8
Majeed, Y.9
Milligan, C.J.10
Bahnasi, Y.M.11
Al-Shawaf, E.12
Porter, K.E.13
Jiang, L.-H.14
Emery, P.15
Sivaprasadarao, A.16
Beech, D.J.17
-
7
-
-
78650057571
-
Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin
-
Azimi, I.; Matthias, L. J.; Center, R. J.; Wong, J. W. H.; Hogg, P. J. Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin J. Biol. Chem. 2010, 285, 40072-40080
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 40072-40080
-
-
Azimi, I.1
Matthias, L.J.2
Center, R.J.3
Wong, J.W.H.4
Hogg, P.J.5
-
8
-
-
57649149732
-
Identification of human thioredoxin as a novel IFN-gamma induced factor: Mechanism of induction and its role in cytokine production
-
Kim, S.; Oh, J.; Choi, J.; Jang, J.; Kang, M. Identification of human thioredoxin as a novel IFN-gamma induced factor: Mechanism of induction and its role in cytokine production BMC Immunol. 2008, 9, 1-15
-
(2008)
BMC Immunol.
, vol.9
, pp. 1-15
-
-
Kim, S.1
Oh, J.2
Choi, J.3
Jang, J.4
Kang, M.5
-
9
-
-
80054827687
-
Activation of extracellular transglutaminase 2 by thioredoxin
-
Jin, X.; Stamnaes, J.; Klöck, C.; Diraimondo, T. R.; Sollid, L. M.; Khosla, C. Activation of extracellular transglutaminase 2 by thioredoxin J. Biol. Chem. 2011, 286, 37866-37873
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 37866-37873
-
-
Jin, X.1
Stamnaes, J.2
Klöck, C.3
Diraimondo, T.R.4
Sollid, L.M.5
Khosla, C.6
-
10
-
-
0031779478
-
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
-
Molberg, O.; Mcadam, S. N.; Körner, R.; Quarsten, H.; Kristiansen, C.; Madsen, L.; Fugger, L.; Scott, H.; Norén, O.; Roepstorff, P.; Lundin, K. E.; Sjöström, H.; Sollid, L. M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease Nat. Med. 1998, 4, 713-717
-
(1998)
Nat. Med.
, vol.4
, pp. 713-717
-
-
Molberg, O.1
McAdam, S.N.2
Körner, R.3
Quarsten, H.4
Kristiansen, C.5
Madsen, L.6
Fugger, L.7
Scott, H.8
Norén, O.9
Roepstorff, P.10
Lundin, K.E.11
Sjöström, H.12
Sollid, L.M.13
-
11
-
-
0032528813
-
Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity
-
van de Wal, Y.; Kooy, Y.; van Veelen, P.; Peña, S.; Mearin, L.; Papadopoulos, G.; Koning, F. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity J. Immunol. 1998, 161, 1585-1588
-
(1998)
J. Immunol.
, vol.161
, pp. 1585-1588
-
-
Van De Wal, Y.1
Kooy, Y.2
Van Veelen, P.3
Peña, S.4
Mearin, L.5
Papadopoulos, G.6
Koning, F.7
-
12
-
-
46749147598
-
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury
-
Siegel, M.; Strnad, P.; Watts, R. E.; Choi, K.; Jabri, B.; Omary, M. B.; Khosla, C. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury PLoS ONE 2008, 3, e1861
-
(2008)
PLoS ONE
, vol.3
, pp. 1861
-
-
Siegel, M.1
Strnad, P.2
Watts, R.E.3
Choi, K.4
Jabri, B.5
Omary, M.B.6
Khosla, C.7
-
13
-
-
0028828948
-
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma
-
Nilsen, E. M.; Lundin, K. E.; Krajci, P.; Scott, H.; Sollid, L. M.; Brandtzaeg, P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma Gut 1995, 37, 766-776
-
(1995)
Gut
, vol.37
, pp. 766-776
-
-
Nilsen, E.M.1
Lundin, K.E.2
Krajci, P.3
Scott, H.4
Sollid, L.M.5
Brandtzaeg, P.6
-
14
-
-
2042470971
-
Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene
-
Matsui, M.; Oshima, M.; Oshima, H.; Takaku, K.; Maruyama, T.; Yodoi, J.; Taketo, M. M. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene Dev. Biol. 1996, 178, 7-7
-
(1996)
Dev. Biol.
, vol.178
, pp. 7-7
-
-
Matsui, M.1
Oshima, M.2
Oshima, H.3
Takaku, K.4
Maruyama, T.5
Yodoi, J.6
Taketo, M.M.7
-
15
-
-
0031308317
-
Redox active disulfides: The thioredoxin system as a drug target
-
Kirkpatrick, D. L.; Ehrmantraut, G.; Stettner, S.; Kunkel, M.; Powis, G. Redox active disulfides: The thioredoxin system as a drug target Oncol. Res. 1997, 9, 351-356
-
(1997)
Oncol. Res.
, vol.9
, pp. 351-356
-
-
Kirkpatrick, D.L.1
Ehrmantraut, G.2
Stettner, S.3
Kunkel, M.4
Powis, G.5
-
16
-
-
0031466528
-
Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs
-
Kunkel, M. W.; Kirkpatrick, D. L.; Johnson, J. I.; Powis, G. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs Anticancer Drugs 1997, 12, 659-670
-
(1997)
Anticancer Drugs
, vol.12
, pp. 659-670
-
-
Kunkel, M.W.1
Kirkpatrick, D.L.2
Johnson, J.I.3
Powis, G.4
-
17
-
-
34247507112
-
A phase i pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
-
Ramanathan, R. K.; Kirkpatrick, D. L.; Belani, C. P.; Friedland, D.; Green, S. B.; Chow, H.-H. S.; Cordova, C. A.; Stratton, S. P.; Sharlow, E. R.; Baker, A.; Dragovich, T. A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors Clin. Cancer Res. 2007, 13, 2109-2114
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 2109-2114
-
-
Ramanathan, R.K.1
Kirkpatrick, D.L.2
Belani, C.P.3
Friedland, D.4
Green, S.B.5
Chow, H.-H.S.6
Cordova, C.A.7
Stratton, S.P.8
Sharlow, E.R.9
Baker, A.10
Dragovich, T.11
-
18
-
-
79953784421
-
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
-
Ramanathan, R. K.; Abbruzzese, J.; Dragovich, T.; Kirkpatrick, L.; Guillen, J. M.; Baker, A. F.; Pestano, L. A.; Green, S.; Hoff, D. D. A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination Cancer Chemother. Pharmacol. 2011, 67, 503-509
-
(2011)
Cancer Chemother. Pharmacol.
, vol.67
, pp. 503-509
-
-
Ramanathan, R.K.1
Abbruzzese, J.2
Dragovich, T.3
Kirkpatrick, L.4
Guillen, J.M.5
Baker, A.F.6
Pestano, L.A.7
Green, S.8
Hoff, D.D.9
-
19
-
-
0032055646
-
Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides
-
Kirkpatrick, D. L.; Kuperus, M.; Dowdeswell, M.; Potier, N.; Donald, L. J.; Kunkel, M.; Berggren, M.; Angulo, M.; Powis, G. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides Biochem. Pharmacol. 1998, 55, 987-994
-
(1998)
Biochem. Pharmacol.
, vol.55
, pp. 987-994
-
-
Kirkpatrick, D.L.1
Kuperus, M.2
Dowdeswell, M.3
Potier, N.4
Donald, L.J.5
Kunkel, M.6
Berggren, M.7
Angulo, M.8
Powis, G.9
-
20
-
-
84858643071
-
Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: Implications for celiac sprue therapy
-
Diraimondo, T. R.; Klöck, C.; Khosla, C. Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: Implications for celiac sprue therapy J. Pharmacol. Exp. Ther. 2012, 341, 104-114
-
(2012)
J. Pharmacol. Exp. Ther.
, vol.341
, pp. 104-114
-
-
Diraimondo, T.R.1
Klöck, C.2
Khosla, C.3
-
21
-
-
33845501601
-
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles
-
Watts, R. E.; Siegel, M.; Khosla, C. Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles J. Med. Chem. 2006, 49, 7493-7501
-
(2006)
J. Med. Chem.
, vol.49
, pp. 7493-7501
-
-
Watts, R.E.1
Siegel, M.2
Khosla, C.3
-
22
-
-
0001494424
-
Structure-reactivity correlations for the thiol-disulfide interchange reaction
-
Wilson, J.; Bayer, R.; Hupe, D. Structure-reactivity correlations for the thiol-disulfide interchange reaction J. Am. Chem. Soc. 1977, 99, 7922-7926
-
(1977)
J. Am. Chem. Soc.
, vol.99
, pp. 7922-7926
-
-
Wilson, J.1
Bayer, R.2
Hupe, D.3
-
23
-
-
33847087446
-
Rate constants and equilibrium constants for thiol-disulfide interchange reactions involving oxidized glutathione
-
Szajewski, R.; Whitesides, G. Rate constants and equilibrium constants for thiol-disulfide interchange reactions involving oxidized glutathione J. Am. Chem. Soc. 1980, 102, 2011-2026
-
(1980)
J. Am. Chem. Soc.
, vol.102
, pp. 2011-2026
-
-
Szajewski, R.1
Whitesides, G.2
-
24
-
-
33845283266
-
Structure-reactivity relations for thiol-disulfide interchange
-
Houk, J.; Whitesides, G. Structure-reactivity relations for thiol-disulfide interchange J. Am. Chem. Soc. 1987, 109, 6825-6836
-
(1987)
J. Am. Chem. Soc.
, vol.109
, pp. 6825-6836
-
-
Houk, J.1
Whitesides, G.2
-
25
-
-
0347719283
-
Theoretical insights into the mechanism for thiol/disulfide exchange
-
Fernandes, P. A.; Ramos, M. J. Theoretical insights into the mechanism for thiol/disulfide exchange Chemistry 2004, 10, 257-266
-
(2004)
Chemistry
, vol.10
, pp. 257-266
-
-
Fernandes, P.A.1
Ramos, M.J.2
-
28
-
-
0025865875
-
Substitution of the conserved tryptophan 31 in Escherichia coli thioredoxin by site-directed mutagenesis and structure-function analysis
-
Krause, G.; Holmgren, A. Substitution of the conserved tryptophan 31 in Escherichia coli thioredoxin by site-directed mutagenesis and structure-function analysis J. Biol. Chem. 1991, 266, 4056-4066
-
(1991)
J. Biol. Chem.
, vol.266
, pp. 4056-4066
-
-
Krause, G.1
Holmgren, A.2
-
29
-
-
22844442461
-
Thioredoxin: Friend or foe in human disease?
-
Burke-Gaffney, A.; Callister, M. E. J.; Nakamura, H. Thioredoxin: Friend or foe in human disease? Trends Pharmacol. Sci. 2005, 26, 398-404
-
(2005)
Trends Pharmacol. Sci.
, vol.26
, pp. 398-404
-
-
Burke-Gaffney, A.1
Callister, M.E.J.2
Nakamura, H.3
-
30
-
-
84870359579
-
Regulation of the activities of the mammalian transglutaminase family of enzymes
-
Klöck, C.; Khosla, C. Regulation of the activities of the mammalian transglutaminase family of enzymes Protein Sci. 2012, 21, 1781-1791
-
(2012)
Protein Sci.
, vol.21
, pp. 1781-1791
-
-
Klöck, C.1
Khosla, C.2
-
31
-
-
84855787788
-
Transglutaminase 2: A molecular Swiss army knife
-
Gundemir, S.; Colak, G.; Tucholski, J.; Johnson, G. V. W. Transglutaminase 2: A molecular Swiss army knife Biochim. Biophys. Acta 2012, 1823, 406-419
-
(2012)
Biochim. Biophys. Acta
, vol.1823
, pp. 406-419
-
-
Gundemir, S.1
Colak, G.2
Tucholski, J.3
Johnson, G.V.W.4
-
32
-
-
82955250010
-
Celiac disease and transglutaminase 2: A model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders
-
Sollid, L. M.; Jabri, B. Celiac disease and transglutaminase 2: A model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders Curr. Opin. Immunol. 2011, 23, 732-738
-
(2011)
Curr. Opin. Immunol.
, vol.23
, pp. 732-738
-
-
Sollid, L.M.1
Jabri, B.2
-
33
-
-
0026602786
-
Synthesis and evaluation of imidazolyl disulfides for selective cytotoxicity to hypoxic EMT6 tumor cells in vitro
-
Kirkpatrick, D.; Jimale, M.; King, K.; Chen, T. Synthesis and evaluation of imidazolyl disulfides for selective cytotoxicity to hypoxic EMT6 tumor cells in vitro Eur. J. Med. Chem. 1992, 27, 33-37
-
(1992)
Eur. J. Med. Chem.
, vol.27
, pp. 33-37
-
-
Kirkpatrick, D.1
Jimale, M.2
King, K.3
Chen, T.4
-
34
-
-
77249179133
-
Selective benzimidazole inhibitors of the antigen receptor-mediated NF-κB activation pathway
-
Okolotowicz, K. J.; Shi, R.; Zheng, X.; MacDonald, M.; Reed, J. C.; Cashman, J. R. Selective benzimidazole inhibitors of the antigen receptor-mediated NF-κB activation pathway Bioorg. Med. Chem. 2010, 18, 1918-1924
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 1918-1924
-
-
Okolotowicz, K.J.1
Shi, R.2
Zheng, X.3
MacDonald, M.4
Reed, J.C.5
Cashman, J.R.6
-
35
-
-
0006895581
-
Measurement of thioredoxin and thioredoxin reductase
-
Arnér, E. S.; Holmgren, A. Measurement of thioredoxin and thioredoxin reductase Curr. Protoc. Toxicol. 2001, 24, 7.4.1-7.4.14
-
(2001)
Curr. Protoc. Toxicol.
, vol.24
, pp. 741-7414
-
-
Arnér, E.S.1
Holmgren, A.2
-
36
-
-
79960029361
-
SwissDock, a protein-small molecule docking web service based on EADock DSS
-
Grosdidier, A.; Zoete, V.; Michielin, O. SwissDock, a protein-small molecule docking web service based on EADock DSS Nucleic Acids Res. 2011, 39, W270-W277
-
(2011)
Nucleic Acids Res.
, vol.39
-
-
Grosdidier, A.1
Zoete, V.2
Michielin, O.3
-
37
-
-
4444221565
-
UCSF Chimera-A visualization system for exploratory research and analysis
-
Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-A visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612
-
(2004)
J. Comput. Chem.
, vol.25
, pp. 1605-1612
-
-
Pettersen, E.F.1
Goddard, T.D.2
Huang, C.C.3
Couch, G.S.4
Greenblatt, D.M.5
Meng, E.C.6
Ferrin, T.E.7
|